Back

The predictive value of left atrial diameter for thrombotic risk in patients with left ventricular noncompaction

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Diagnostic methods in cardiac amyloidosis and other rare cardiomyopathies Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Wei Xu

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)

6 More presentations in this session

Presentation thumbnail
Cardiac injury before and after COVID-19. A longitudinal MRI study
Doctor T. Althoff (Berlin, DE)
Abstract Slides
Presentation thumbnail
Early subclinical systolic dysfunction detected by two-dimensional speckle tracking systolic strain in patients with hereditary TTR amyloidosis
Miss L. Squassante Capeline (Sao Paulo, BR)
Abstract Slides
Presentation thumbnail
Validation of an electrocardiographic algorithm for the detection of cardiac amyloidosis
Doctor L. Schrutka (Vienna, AT)
Abstract Slides
Presentation thumbnail
Prognostic value of left ventricle global constructive work in patients with cardiac amyloidosis
Doctor J. Geers (Jette, BE)
Abstract Slides
Presentation thumbnail
Echocardiographic evolution of patients undergoing 99mTc-DPD scintigraphy for suspected cardiac amyloidosis
Mrs N. Ramos Lopez (Madrid, ES)
Abstract Slides

Access the full session

Session thumbnail
Diagnostic methods in cardiac amyloidosis and other rare cardiomyopathies

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources